selected publications
-
Radical Trachelectomy for the Treatment of Early-Stage Cervical Cancer: A Systematic Review.
Obstetrics and gynecology.
2020
Academic Article
GET IT
Times cited: 33 -
Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study.
Gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 9 -
Fertility-sparing treatment in early endometrial cancer: current state and future strategies.
Obstetrics & gynecology science.
2020
Academic Article
GET IT
Times cited: 3 -
Improving response to progestin treatment of low-grade endometrial cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2020
Review
GET IT
Times cited: 15 -
Positron Lymphography via Intracervical 18F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial Malignancies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2020
Academic Article
GET IT
Times cited: 6 -
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.
Gynecologic oncology.
2019
Academic Article
GET IT
Times cited: 44 -
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Gynecologic oncology.
2019
Academic Article
GET IT
Times cited: 25 - Robotic-assisted psoas hitch with ureteral reimplantation. 2019 GET IT
-
Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 21 -
Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 11 - Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18]. Gynecologic oncology. 2016 Academic Article GET IT
-
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 3 -
Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type.
The American journal of surgical pathology.
2016
Academic Article
GET IT
Times cited: 67 -
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 95 -
Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2015
Academic Article
GET IT
Times cited: 47 -
Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.
Nature genetics.
2014
Academic Article
GET IT
Times cited: 246